Gastroenterology and Hepatology最新文献_第2页

Women in Advanced Endoscopy. 高级内窥镜检查中的女性。

Gastroenterology and Hepatology Pub Date : 2025-04-01

Ashley L Faulx

引用次数: 0

Raising Expectations in IBS-C Management. IBS-C管理期望值的提高。

Gastroenterology and Hepatology Pub Date : 2025-04-01

Kyle Staller

引用次数: 0

Dermatologic Conditions That Can Involve the Esophagus. 可累及食道的皮肤病。

Gastroenterology and Hepatology Pub Date : 2025-04-01

David Katzka

引用次数: 0

Overview of Metabolic Dysfunction-Associated Steatohepatitis in Children. 儿童代谢功能障碍相关脂肪性肝炎综述

Gastroenterology and Hepatology Pub Date : 2025-04-01

Rohit Kohli

引用次数: 0

Female Representation in Advanced Endoscopy. 女性在高级内窥镜检查中的表现。

Gastroenterology and Hepatology Pub Date : 2025-04-01

Gary R Lichtenstein

引用次数: 0

Overcoming Challenges in Electronic Health Record Use in Inflammatory Bowel Disease Care. 克服电子健康记录在炎症性肠病护理中的挑战。

Gastroenterology and Hepatology Pub Date : 2025-04-01

Hasan Saleh, Sara Horst, Jami Kinnucan

{"title":"Overcoming Challenges in Electronic Health Record Use in Inflammatory Bowel Disease Care.","authors":"Hasan Saleh, Sara Horst, Jami Kinnucan","doi":"","DOIUrl":"","url":null,"abstract":"Electronic health record (EHR) systems were introduced to enhance patient data accessibility and improve care. However, in gastroenterology, particularly in the management of inflammatory bowel disease (IBD), EHRs often place a significant burden on providers. Provider burnout is a growing issue, with EHR tasks such as extensive clinical review, in-basket messaging, and office visit charting contributing to inefficiencies in complex IBD management. These challenges highlight the need for improved EHR workflows in IBD patient care. Although research suggests that effective EHR utilization can reduce burnout, standardizing strategies across IBD centers remains challenging owing to diverse systems and regulations. Previous efforts in EHR optimization have included multicenter learning systems and smaller interventions, such as documentation tools, note templates, order sets, provider checklists, and care pathways, among others. Despite these advances, barriers to standardization persist, mainly owing to differing EHR platforms and regulatory frameworks across IBD practices. To address these challenges, practical solutions for IBD providers are needed. EHR tools such as standardized text, order preference lists, standardized note templates, patient questionnaires, and clinical information summaries offer potential for optimization. We propose the development of an EHR IBD Care Roadmap, providing standardized guidance to help clinicians optimize the use of these tools and improve the quality of IBD care. Collaboration among clinician leaders, national committees, and health information technology experts is essential for successful EHR optimization and standardization. This article explores the gaps in EHR utilization and proposes strategies for optimization in the care of IBD patients.","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"21 4","pages":"241-246"},"PeriodicalIF":0.0,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100534/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144144470","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Exploring Screening for Colorectal Cancer. 探讨结直肠癌的筛查。

Gastroenterology and Hepatology Pub Date : 2025-03-01

Gary R Lichtenstein

引用次数: 0

Management of Uncomplicated Luminal Crohn's Disease. 无并发症腔内克罗恩病的治疗。

Gastroenterology and Hepatology Pub Date : 2025-03-01

引用次数: 0

The Evolving Role of Weight Loss Pharmacotherapy. 减肥药物治疗作用的演变。

Gastroenterology and Hepatology Pub Date : 2025-03-01

Shayan Amini, Daniel A Burkholder, Ronan P Allencherril, Raj Shah, Thomas R McCarty

{"title":"The Evolving Role of Weight Loss Pharmacotherapy.","authors":"Shayan Amini, Daniel A Burkholder, Ronan P Allencherril, Raj Shah, Thomas R McCarty","doi":"","DOIUrl":"","url":null,"abstract":"Obesity is a complex disease, afflicting millions of individuals worldwide. Multiple treatment options exist, including dietary and lifestyle modifications, pharmacotherapy, endobariatrics, and surgery. Although diet and exercise remain crucial to the long-term management of obesity, their effectiveness as monotherapy is limited. Adjunctive therapy, therefore, has become a tool associated with more durable weight loss results. This article serves to explore the expanding pharmacologic options available for the treatment of obesity. Traditional pharmacotherapy includes phentermine/topiramate and bupropion/naltrexone, both of which have been shown to aid in weight loss. More recent novel therapies include glucagon-like peptide-1 (GLP-1) and GLP-1/glucose-dependent insulinotropic polypeptide receptor agonists, which have shown even more marked weight loss and improvement in obesity-associated comorbid conditions compared with alternative medications. Despite their effectiveness, barriers to widespread use include their cost, insurance approval, and side effect profile. Further studies are underway examining the role of pharmacotherapy in conjunction with endoscopic bariatric therapies as well as bariatric surgery.","PeriodicalId":52498,"journal":{"name":"Gastroenterology and Hepatology","volume":"21 3","pages":"172-179"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11920015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143671845","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Azathioprine or Mycophenolate Mofetil: Which Should Be Used in Patients With Autoimmune Hepatitis? 硫唑嘌呤还是霉酚酸酯？自身免疫性肝炎患者应该使用哪种疗法？

Gastroenterology and Hepatology Pub Date : 2025-03-01

Alan Bonder

引用次数: 0